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Research Interests in Zhao Group
Pathways and Genomes
• Phloroglucinol biosynthesis
• FR900098 biosynthesis
• Xylitol biosynthesis
• Advanced biofuels
• Alkaloid biosynthesis
Synthetic Biology
Tool Development
• Directed evolution
• Rational design
• High throughput methods
• Biosynthesis
• Genome engineering
Synthesis
Analysis
Grand Challenge #1 (Energy & Sustainability): Urgent need for oil replacement
 Use renewable feedstocks to produce fuels, chemicals, and drugs
Grand Challenge #2 (Health): Need for new therapeutics
Proteins
• Gene switches/circuits
• Artificial nucleases
• P450 enzymes
• Type III PKS
• N-Oxygenases
Modeling
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Overall Goal: Develop and apply systems and synthetic biology approaches to 
engineer microorganisms capable of cost-effectively producing industrial 
chemicals from renewable feedstocks. 
Tool Development
• Computational
• Genetic manipulation
&
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Tools Driving Biotechnology
First Generation Biotech
Recombinant DNA Technology
“Cut and paste”
PCR
“DNA Amplification”
DNA Sequencing
“Read out the genetic code”
First product: human insulin, produced in E. coli in 1978.
- Recombinant human growth hormone 
- Recombinant blood clotting factor VIII
- ……
Global market size for recombinant proteins: ~$60B in 2009
human insulin
Transformative Advances in 
DNA Sequencing and Synthesis
Carlson, Nat. Biotech. 27, 1091 (2009)
Carr and Church, Nat. Biotech. 27, 1151 (2009)
?10-1000’s genescomplex chemicals and materialsorganisms as products 
...
Building Large DNA Molecules via 
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Biofuels Production
Wen et al. Current Opinion in Biotech. (2009)
Gibson et al. PNAS
Online publication date: Dec. 10, 2008
Shao et al. Nucleic Acids Res. 
Online publication date: Dec. 12, 2008
Discovering New Drugs
Activating Cryptic Pathways from 
Sequenced Genomes and Metagenomes
News & Views: 
Cobb and Zhao, Nature Biotech 2012
Engineering a Microbial Factory for 
Advanced Biofuels Production
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Glucose Repression in Mixed 
Sugar Fermentation
 Glucose repression occurs in S. cerevisiae
 Alternative carbon source fermentation is inhibited in the presence 
of glucose
 Lag time in xylose and arabinose consumption curve
Olsson et al.  Appl Microbiol Biotechnol (2009) 82:909–919
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Coexpression of Cellobiose
Transporter and β-Glucosidase
 Cellodextrin transport system from Neurospora crassa
 Cellodextrin transporters: NCU00801 (cdt1), NCU00809, NCU08114(cdt2)
 β-glucosidase: NCU00130 (gh1-1)
Galazka JM, et al. Science 330, 84 (2010)
 S. cerevisiae with a heterologous cellodextrin transport system showed 
improved growth rate. 
Coexpression of Cellobiose
Transporter and β-Glucosidase
 Genes
 3 transporters: cdt-1, cdt-2, 
NCU00809
 2 β-glucosidases: 
gh1-1 from N. crassa, 
bgl1 from A. aculeatus
pRS425
PYK1 
promoter
β-glucosidase
TEF1 
promoter
cellobiose 
transporter
PGK1 
terminator
 Plasmids
 Use DNA assembler method 
to integrate genes into 
pRS425 plasmid
 Strains
 6 plasmids constructed were 
transformed into S. cerevisiae
strain with an integrated xylose
utilization pathway
ADH1 
terminator
Strain Transporter β-glucosidase
SL01 cdt1 gt1-1
SL02 NCU00809 gt1-1
SL03 cdt2 gt1-1
SL04 cdt1 bgl1
SL05 NCU00809 bgl1
SL06 cdt2 bgl1
SL00 - -
Mixed Sugar Cultivation in Shake-
flask: Cellobiose+Xylose
SL01 SL00
SL01 SL00
Yield ethanol 0.28 0.22
Productivity ethanol  (g/(L h)) 0.23 0.07
cellobiose (■) , xylose  (▲), glucose(●), ethanol (▼) , Dry cell weight (□)
Mixed Sugar Cultivation in 
Bioreactor: Cellobiose+Xylose
SL01 SL00
cellobiose (■) , xylose  (▲), glucose(●), ethanol (▼) , Dry cell weight (□)
SL01 SL00
Yield ethanol 0.39 0.24
Productivity ethanol  (g/(L h)) 0.49 0.09
Li et al. Mol Biosyst 2010
Balancing Metabolic Flux Remains a 
Big Challenge
 Production of value-added compounds usually requires introduction of 
multi-step metabolic pathways
 Metabolic flux in multistep metabolic pathways need to be optimized to 
avoid metabolic burden 
 Overexpression of certain genes, 
 Redox imbalance from unmatched cofactor specificity
 Accumulation of unstable or toxic intermediates
 Traditional approaches
 Overexpression and deletion of certain genes in metabolic pathways
 Modulating the expression levels of individual enzymes
 Protein engineering to improve performance of rate limiting enzymes
 Targeting a specific enzyme instead of the overall pathway
 Simultaneous optimization of multiple metabolic genes remains a big 
challenge
Balancing Metabolic Flux Remains a 
Big Challenge
 Perturbation of global transcription machinery
 Genome-scale mapping of fitness altering genes
 Multiplex genome engineering
 Balance metabolic flux within the target pathway
 Strengths of promoters
 Ribosome binding sites
Intergenic regions
 Synthetic scaffolds
Pfleger et al.,Nat Biotechnol 24, 1027-1032 (2006)
Dueber et al., Nat Biotechnol 27, 753-759 (2009)
Alper et al.,  Metab Eng 9, 258-267 (2007)
Warnecke et al., Metab Eng 12, 241-250 (2010)
Warner et al., Nature Biotechnology 28, 856-U138 (2010)
Wang et al., Nature 460, 894-898 (2009)
Salis et al.,  Nat Biotechnol 27, 946-950 (2009)
Alper et al., Proc Natl Acad Sci U S A 102, 12678-12683 (2005)
Pathway Optimization 
by COMPACTER
Customized Optimization of Metabolic Pathways by Combinatorial 
Transcriptional Engineering (COMPACTER)
Target pathway
Gene3 Terminator3Gene2 Terminator2Gene1 Terminator1Promoter1 Promoter2 Promoter3
Promoter1
Promoter1
Screening/selection of mutant pathways with desired phenotype
Combinatorial assembly of a library of mutant pathways
Gene1
Terminator2
Terminator2 Terminator3Gene3Terminator1
Terminator1 Gene2
Promoter1
control
 Selected 6 yeast promoters
 Nucleotide analogue mutagenesis
 Isolating promoter mutants via FACS
Promoter Mutants with 
Varying Strength
TEF1
TPI1
GPM1
GPD
FBA1
PDC1
ENO2
PYK1
TEF2
PGK1
HXT7
TDH2
ADH1
PGI1
0 2000 4000 6000 8000 10000 12000
Mean Fluorescence of GFP
P
r
o
m
o
t
e
r
s
 
u
s
e
d
 
i
n
 
c
a
s
s
e
t
t
e
 Oxygen-limited
 Oxygen-abundant
Alper et al. PNAS 102, 12678-12683 (2005)
Sun et al. B&B, 2012
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Pathway Optimization 
by COMPACTER
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Xylose Utilizing Pathway Cellobiose Utilizing Pathway
 Host strain: INVSc1 (Invitrogen)
 Diploid, auxotrophic mutation available
 Control
 pRS416-PDC1p(WT)-csXR-TEF1p(WT)-ctXDH-ENO2p(WT)-ppXKS
 Backbone: pRS416 
 Single copy shuttle vector
 Library size: 104~105
 Fermentation:
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INVSc1
Optimization of the Xylose Utilizing 
Pathway in the INVSc1 Strain
 Initial OD~1
 Oxygen limited condition
 YP media
WT S3 Unit
Xylose 
consumption rate
0.24 0.40 g/L/hr
Ethanol 
production rate
0.04 0.10 g/L/hr
Ethanol yield 0.16 0.25
g/g 
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Optimization of the Xylose Utilizing 
Pathway in an Industrial Strain
 Host Strain
 Still Spirits (Classic) Turbo Distiller's Yeast
 Control
 pRS-KanMX-PDC1p(WT)-csXR-TEF1p(WT)-ctXDH-ENO2p(WT)-ppXKS
 Backbone:pRS-KanMX
 Single copy shuttle vector
 Library size: 103~104
 Fermentation:
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 Initial OD~10
 Oxygen limited condition
 YP media
YPD seed YPX seed
Unit
Classic WT Classic S7 Classic S7
Xylose 
consumption 
rate
0.06 0.74 0.92 g/L/hr
Ethanol 
production 
rate
0 0.17 0.24 g/L/hr
Ethanol yield 0 0.24 0.26 g/g xylose
xylose (■), ethanol (▼) 
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Host-specific Pathway 
Optimization
 Switching optimized xylose utilizing pathways 
between laboratory and industrial strains
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xylose (■), ethanol (▼) 
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Host-specific Pathway 
Optimization
 qPCR analysis of the optimized xylose utilizing pathways 
between laboratory and industrial strains

Optimization of the Cellobiose
Utilizing Pathway
Optimized Xylose Utilizing 
Pathways are Strain Specific
Open symbol: pathway optimized in INVSc1 strain, Solid symbol: pathway optimized in Classic 
strain, Red circle: cellobiose, Black square: OD (A600), Blue down triangle: ethanol. 
Optimized Cellobiose Utilizing 
Pathways are Strain Specific
 qPCR analysis of the optimized cellobiose utilizing 
pathways between laboratory and industrial strains

Directed Evolution for Strain 
Development
Local Optimization
Global Optimization
Directed Evolution for Strain 
Development
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 #9,#91 and #9118 have same 
final OD, ethanol 
concentration and glucose 
accumulation
 A#9118 has lower OD and 
higher ethanol 
 A#9118 has much lower 
glucose accumulation
 No mutations were found in 
promoter regions in A#9118
Directed Evolution for Strain 
Development
Cellobiose fermentation performance of evolved yeast 
strains #9, #9-1, #9-1-18 and A#9-1-18
Consolidated Bioprocessing (CBP)
Recombinant microbe:
• Cellulolytic 
• Ethanogenic (yeast)
Cellulosic biomass
Pretreatment
Cellulases
production
Cellulose 
hydrolysis Fermentation 
Cellulosic biomass
Pretreatment
Development towards 
 Consolidated bioprocessing (CBP): save ~10-20 cents/gallon of ethanol
SSF
Fermentation of 
cellulosic sugars
of hemicellulosic 
sugars
Ethanol Ethanol
Direct conversion 
of pretreated 
cellulosic biomass 
into ethanol 
more consolidated process
L. Lynd et al. Curr Opin Biotechnol 577 (2005)
Direct Conversion of Cellulose to Ethanol 
by Engineered Mini-cellulosomes
•EG: Endogluconase
•CBH: Exogluconase
•BG: β-glucosidase
Yeast cell wall
mini-scaffoldin
CBH
BGL
Glucose Cello-oligosaccharides
EG
 Yeast surface display of functional minicellulosomes
 Functional display of a mini-scaffoldin
 Successful assembly of minicellulosomes through 
cohesin-dockerin interaction
 Synergistic hydrolysis of cellulose
 Direct fermentation of hydrolysate (glucose) to ethanol
Direct Ethanol Production from PASC
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Ethanol production Residual PASC
Wen, F., Sun, J. and Zhao, H. AEM (2010)
Yield: 0.31 grams of ethanol per gram of PASC
62% of theoretical yield
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Direct Conversion of Xylan to Ethanol 
by Engineered Hemicellulosomes
Sun, J. et al. AEM (2012)
Direct Conversion of Xylan to Ethanol 
by Engineered Hemicellulosomes
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Sun, J. et al. AEM (2012)
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Yield: 0.31 grams of ethanol per gram of 
birchwood xylan
Summary
• Developed a DNA assembler method for constructing large 
DNA molecules such as pathways, plasmids, and genomes. 
• Developed a DNA assembler based synthetic biology method 
(COMPACTER) for optimizing the metabolic flux in a 
heterologous pathway
• Engineered a yeast strain capable of simultaneously and 
efficiently utilizing C5/C6 sugars
• Engineered yeast strains for consolidated bioprocessing of 
cellulose and xylan respectively. 
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